Literature DB >> 19539611

Epigallocatechin-3-gallate is an inhibitor of Na+, K(+)-ATPase by favoring the E1 conformation.

Hideo Ochiai1, Kazuo Takeda, Shiori Soeda, Yoshikazu Tahara, Hitoshi Takenaka, Kazuhiro Abe, Yutaro Hayashi, Shunsuke Noguchi, Masumi Inoue, Silvia Schwarz, Wolfgang Schwarz, Masaru Kawamura.   

Abstract

Four catechins, epigallocatechin-3-gallate, epigallocatechin, epicatechin-3-gallate, and epicatechin, inhibited activity of the Na(+),K(+)-ATPase. The two galloyl-type catechins were more potent inhibitors, with IC(50) values of about 1 microM, than were the other two catechins. Inhibition by epigallocatechin-3-gallate was noncompetitive with respect to ATP. Epigallocatechin-3-gallate reduced the affinity of vanadate, shifted the equilibrium of E1P and E2P toward E(1)P, and reduced the rate of the E1P to E2P transition. Epigallocatechin-3-gallate potently inhibited membrane-embedded P-type ATPases (gastric H+, K(+)-ATPase and sarcoplasmic reticulum Ca(2+)-ATPase) as well as the Na(+),K(+)-ATPase, whereas soluble ATPases (bacterial F(1)-ATPase and myosin ATPase) were weakly inhibited. Solubilization of the Na(+),K(+)-ATPase with a nonionic detergent reduced sensitivity to epigallocatechin-3-gallate with an elevation of IC50 to 10 microM. These results suggest that epigallocatechin-3-gallate exerts its inhibitory effect through interaction with plasma membrane phospholipid.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19539611     DOI: 10.1016/j.bcp.2009.06.007

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  2 in total

1.  Ivermectin is a nonselective inhibitor of mammalian P-type ATPases.

Authors:  Paulo Henrique Cotrim Pimenta; Claudia Lucia Martins Silva; François Noël
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-30       Impact factor: 3.000

2.  Flavonoids in prevention of diseases with respect to modulation of Ca-pump function.

Authors:  Lubica Horáková
Journal:  Interdiscip Toxicol       Date:  2011-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.